• News

    Market Watch

    November 1, 2010

    The latest news about new generics, indications, and safety information

  • News

    Innovative Use of Scribes in the Inpatient Setting

    October 1, 2010

    Over the past couple of decades, the ever-increasing medical-legal, financial, and patient-safety demands have led to a mushrooming of the amount of documentation needed during patient care, especially in the inpatient setting.

  • 1
    News

    Can You Hear Me Now?

    October 1, 2010

    SHM expands quality improvement reach to hospitals far and wide

  • News

    Market Watch

    October 1, 2010

    New generics, new indications, and safety information

  • 1
    News

    To Err is Human

    October 1, 2010

    SHM enacts new systems, protocols to eliminate missteps

  • News

    Innovators Descend on Annual Pediatric HM Conference

    September 1, 2010

    More than 400 people attended the Pediatric Hospital Medicine annual conference July 22-25 in Minneapolis.

  • News

    Hospitalist/Intensivist Model Lowers Costs, Maintains Quality of Care

    September 1, 2010

    As the field of HM continues to mature, branch out, and is called upon to lead in the care of a larger cross-section of hospitalized patients, it is only natural that this includes the critically ill patient.

  • News

    Market Watch

    September 1, 2010

    New Generics Desloratadine tablets (generic Clarinex)1 Didanosine delayed-release capsules (Generic Videx EC)2 New Indications, Dosage Forms, and Recommendations Ganciclovir ophthalmic gel 0.15% (Zirgan) has been approved by the FDA for treating acute herpetic keratitis.3 The recommende

  • 1
    News

    Productivity Capacity

    September 1, 2010

    The beginning of what’s next in HM

  • News

    Market Watch

    August 2, 2010

    New Drugs, Indications, Dosage Forms, and Approvals Hydromorphone extended-release tablets (Exalgo) have been approved by the FDA as a once-daily treatment for managing moderate to severe pain in opioid-tolerant patients needing continuous opioid analgesia for an extended period of time.1 This f